Page last updated: 2024-10-25

citalopram and Diabetic Neuropathies

citalopram has been researched along with Diabetic Neuropathies in 1 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research Excerpts

ExcerptRelevanceReference
"Citalopram was given as a fixed dose of 40 mg/day."2.67The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. ( Aaes-Jørgensen, T; Bjerre, U; Brøsen, K; Dejgaard, A; Gram, LF; Sindrup, SH, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sindrup, SH1
Bjerre, U1
Dejgaard, A1
Brøsen, K1
Aaes-Jørgensen, T1
Gram, LF1

Trials

1 trial available for citalopram and Diabetic Neuropathies

ArticleYear
The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy.
    Clinical pharmacology and therapeutics, 1992, Volume: 52, Issue:5

    Topics: Adult; Aged; Citalopram; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Ag

1992